SEC Form 4 · accession 0001144204-18-033336
PHIBRO ANIMAL HEALTH CORP · PAHC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
BFI Co., LLC
10% Owner
Period of report
Jun 5, 2018
Accepted (ET)
Jun 7, 2018 · 9:08 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001069899
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common StockF1,F2 | Jun 5, 2018 | S | 9,444 | $45.83 | D | 48,026 | D | |
| Class A Common StockF1,F3 | Jun 5, 2018 | S | 556 | $46.46 | D | 47,470 | D | |
| Class A Common StockF1,F4 | Jun 6, 2018 | S | 10,000 | $45.83 | D | 37,470 | D | |
| Class A Common StockF1,F5 | Jun 7, 2018 | S | 10,000 | $46.47 | D | 27,470 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2017.
- F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.40 to $46.35, inclusive.
- F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.40 to $46.55, inclusive.
- F4The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.50 to $46.30, inclusive.
- F5The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.15 to $46.80, inclusive.